241 related articles for article (PubMed ID: 25247600)
1. Oncostatin M and leukaemia inhibitory factor trigger signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2 pathways but result in heterogeneous cellular responses in trophoblast cells.
Chaiwangyen W; Ospina-Prieto S; Morales-Prieto DM; Pereira de Sousa FL; Pastuschek J; Fitzgerald JS; Schleussner E; Markert UR
Reprod Fertil Dev; 2016 Apr; 28(5):608-17. PubMed ID: 25247600
[TBL] [Abstract][Full Text] [Related]
2. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
3. Leukaemia inhibitory factor mediated proliferation of HTR-8/SVneo trophoblast cells is dependent on activation of extracellular signal-regulated kinase 1/2.
Prakash GJ; Suman P; Morales Prieto DM; Markert UR; Gupta SK
Reprod Fertil Dev; 2011; 23(5):714-24. PubMed ID: 21635820
[TBL] [Abstract][Full Text] [Related]
4. Effects of Oncostatin M on Invasion of Primary Trophoblasts under Normoxia and Hypoxia Conditions.
Wie JH; Ko HS; Choi SK; Park IY; Kim A; Kim HS; Shin JC
Yonsei Med J; 2018 Sep; 59(7):879-886. PubMed ID: 30091322
[TBL] [Abstract][Full Text] [Related]
5. Intranuclear crosstalk between extracellular regulated kinase1/2 and signal transducer and activator of transcription 3 regulates JEG-3 choriocarcinoma cell invasion and proliferation.
Morales-Prieto DM; Ospina-Prieto S; Chaiwangyen W; Weber M; Hölters S; Schleussner E; Fitzgerald JS; Markert UR
ScientificWorldJournal; 2013; 2013():259845. PubMed ID: 24288470
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
[TBL] [Abstract][Full Text] [Related]
7. Involvement of STAT1 in proliferation and invasiveness of trophoblastic cells.
Pereira de Sousa FL; Chaiwangyen W; Morales-Prieto DM; Ospina-Prieto S; Weber M; Photini SM; Sass N; Daher S; Schleussner E; Markert UR
Reprod Biol; 2017 Sep; 17(3):218-224. PubMed ID: 28552376
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
[TBL] [Abstract][Full Text] [Related]
11. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M stimulates cell migration and proliferation by down-regulating E-cadherin in HTR8/SVneo cell line through STAT3 activation.
Ko HS; Choi SK; Kang HK; Kim HS; Jeon JH; Park IY; Shin JC
Reprod Biol Endocrinol; 2013 Sep; 11():93. PubMed ID: 24060241
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
Liu JW; Hsu YC; Kao CY; Su HL; Chiu IM
Stem Cells Dev; 2013 Apr; 22(8):1190-7. PubMed ID: 23205673
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
[TBL] [Abstract][Full Text] [Related]
15. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
16. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
17. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
El Mabrouk M; Sylvester J; Zafarullah M
Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
[TBL] [Abstract][Full Text] [Related]
18. Identification of miRNAs and associated pathways regulated by Leukemia Inhibitory Factor in trophoblastic cell lines.
Morales-Prieto DM; Barth E; Murrieta-Coxca JM; Favaro RR; Gutiérrez-Samudio RN; Chaiwangyen W; Ospina-Prieto S; Gruhn B; Schleußner E; Marz M; Markert UR
Placenta; 2019 Dec; 88():20-27. PubMed ID: 31586768
[TBL] [Abstract][Full Text] [Related]
19. STAT3 and ERK1/2 cross-talk in leukaemia inhibitory factor mediated trophoblastic JEG-3 cell invasion and expression of mucin 1 and Fos.
Suman P; Gupta SK
Am J Reprod Immunol; 2014 Jul; 72(1):65-74. PubMed ID: 24716848
[TBL] [Abstract][Full Text] [Related]
20. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
